Director

​

Carel is a former S&P Global 100 Intellectual Property counsel, and a medical devices and AgTech entrepreneur. He is also a tri-qualified IP attorney and an internationally recognised business strategist who is a pioneer of innovative IP and monetization strategies. Carel provides key expertise related to IP strategy, which is crucial for successful development of an early-stage MedTech/Biotech business